Jeddah Health Cluster Two Signs Cooperation Agreement with Jamjoom Pharma to Enhance Healthcare
Jeddah Health Cluster Two has signed a strategic cooperation agreement with Jamjoom Pharma, one of the most prominent Saudi companies specializing in the pharmaceutical industry. This partnership aims to develop health services and raise the level of medical awareness in the Kingdom of Saudi Arabia.
This initiative comes within the framework of Jeddah Health Cluster Two's efforts to enhance cooperation with the private sector, in support of the Kingdom's Vision 2030, which seeks to improve the quality of health services provided to citizens and residents. The agreement will focus primarily on the exchange of expertise and the development of human competencies in the medical field.
Through this collaboration, both parties will work on organizing specialized training programs for healthcare workers, in addition to launching awareness campaigns aimed at educating the community about the importance of disease prevention and the correct use of medications. This step will also contribute to supporting innovation and developing therapeutic solutions available in the health facilities affiliated with the cluster.
This agreement is an important step toward strengthening the partnership between the public and private sectors in the Kingdom. It is expected that these efforts will lead to improving the patient experience and providing more efficient and comprehensive healthcare in Jeddah and its surrounding areas.